About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Vera Therapeutics image

Vera Therapeutics

Rank#4570
Market Cap2.45B
CountryUnited States
Summary
History
Mission
Vision
References
Summaryarrow
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Historyarrow

Vera Therapeutics was founded in 2015 by three experienced scientists and healthcare professionals. The company's mission is to develop therapies that will make a meaningful impact in the lives of those suffering from age-related diseases and disorders. Since its founding, the company has secured investments from top investors and developed a strong portfolio of products and technologies to achieve its goal.

Missionarrow
Vera Therapeutics is dedicated to developing new therapies that have the potential to dramatically improve the lives of individuals with age-related diseases and disorders.
Visionarrow
Vera Therapeutics is committed to becoming the leading provider of innovative therapies and technologies for aging-related diseases and disorders.
Referencesarrow

https://in.investing.com/equities/vera-therapeutics

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/trucode-gene-repair

https://finance.yahoo.com/quote/VERA/

https://veratx.com

https://sec.report/CIK/0001831828

Share

Leadership team
D
Dr. Marshall Fordyce M.D. (Founder, Pres, CEO & Director)
M
Mr. Sean P. Grant M.B.A. (Chief Financial Officer)
D
Dr. Celia Lin M.D. (Chief Medical Officer)
Products / Services
Biotechnology, Health Care
Address
South San Francisco, California, United States
Established
2016-01-01
Company Registration
SEC CIK number: 0001831828
Traded as
VERA
Website
https://veratx.com
Social Media
linkedin
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo